StockIQpro
NYSE:ENOV

Enovis CORP

Enovis CORP's revenue grew 6.7% in fiscal 2025 to $2.2B while operating margin fell to −50.0%, its lowest in 10 years. Free cash flow was $19.9M, 0.9% of revenue, and the diluted share count rose 3.2%.Summary generated from Enovis CORP's SEC filings. Latest annual report filed Feb 26, 2026.

Revenue (FY25)$2.2B
Revenue growth+6.7%
Revenue, 5-yr CAGR+14.9%
Gross margin59.8%
Operating margin−50.0%
Net margin−52.7%
ROIC−26.9%
Return on equity−58.5%
Debt / equity0.87
Free cash flow$19.9M
FCF margin0.9%
Share count change+3.2%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue1,4261,5631,7072,1082,248
Operating income−63−71−66−776−1,124
Net income72−13−33−825−1,184
Free cash flow252−16113−6720

Recent filings

From SEC EDGAR

Peers

Orthopedic, prosthetic & surgical appliances & supplies